טוען...
Steady state pharmacokinetics of cycloserine in patients on terizidone for multidrug-resistant tuberculosis
SUMMARY: SETTING: Terizidone/cycloserine (TRD/CS) is included in standard treatment regimens for multidrug-resistant tuberculosis (MDR-TB) in many countries. The steady state pharmacokinetics (PKs) of CS after TRD administration are not known. OBJECTIVES AND DESIGN: We recruited in-patients treated...
שמור ב:
| הוצא לאור ב: | Int J Tuberc Lung Dis |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6766403/ https://ncbi.nlm.nih.gov/pubmed/29297422 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5588/ijtld.17.0475 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|